Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGF-induced Muscle Sensitivity and Exercise-induced Ischemia
NCT03470038Phase 1Completed
- Sponsor
- Aalborg University
- Start
- Mar 2018
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Nerve growth factor in myalgia, sponsored by Aalborg University. Primary endpoint: Muscle Sensitivity at 1 week. Started Mar 2018; status: completed.
02
Drugs
Nerve growth factor
03
Conditions
myalgia
Beyond the preview
Go deeper on NCT03470038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03470038.